Acorah Software Products - Accounts Production 16.8.200 false true 31 October 2024 1 November 2023 false true No description of principal activity 1 November 2024 31 October 2025 31 October 2025 10426164 Dr Charalampos Kartsios Mrs Rosaria Kartsios iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10426164 2024-10-31 10426164 2025-10-31 10426164 2024-11-01 2025-10-31 10426164 frs-core:CurrentFinancialInstruments 2025-10-31 10426164 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 10426164 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 10426164 frs-bus:Micro-entities 2024-11-01 2025-10-31 10426164 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 10426164 frs-bus:Director1 2024-11-01 2025-10-31 10426164 frs-bus:Director2 2024-11-01 2025-10-31 10426164 2023-10-31 10426164 2024-10-31 10426164 2023-11-01 2024-10-31 10426164 frs-core:CurrentFinancialInstruments 2024-10-31
Registered number: 10426164
Kappa Haematology Limited
Unaudited Financial Statements
For The Year Ended 31 October 2025
TaxAssist Accountants
Chartered Accountants
Kappa Haematology Limited
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 10426164

| 2025 | 2024
--- | --- | ---
|  | £ | £
Fixed assets |  | 2,937 | 366
Current assets |  | 92,025 | 75,314
Creditors: Amounts Falling Due Within One Year |  | (10,359 ) | (13,986 )
NET CURRENT ASSETS |  | 81,666 | 61,328
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 84,603 | 61,694
Accruals and deferred income |  | (395 ) | (198 )
NET ASSETS |  | 84,208 | 61,496
CAPITAL AND RESERVES |  | 84,208 | 61,496

## Notes

1. General Information
Kappa Haematology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10426164 . The registered office is 51 School Road, Birmingham, West Midlands, B28 8JG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Charalampos Kartsios Director
19th December 2025